Newcastle University

Research Interests

Basic and clinical science in Lung Transplantation
Main basic group is studying mechanisms leading to airway remodelling following lung transplantation
Main clinical interest is as steering committee member of International Study group organising multicentre clinical studies

Pulmonary vascular disease

Other Expertise

Pulmonary Embolism COPD and Asthma

Current Work

Programme Director of Reseach of Lung group within Immunobiology and Transplantation Research Group
We have ongoing research in
1 MMPs and their role in airway remodelling
2 Role of the innate immune system in the development of OB post lung transplantation
3 gastro oesophageal aspiration and its role in the development of OB post lung transplantation
4 Proinflammatory role of bacterial cell walls and role on epithelial cells of the airway
5 oxidant stress and epithelial cells of the airway
6 EMT and bronchial epithelial cells

Future Research

Pulmonary vascular remodelling

Research Roles

Director of programme of Lung Research in Immunobiology and Transplantation Research Group
Have set up collaborationd with Leiden and Sienna

Postgraduate Supervision

Yes
Supervision of both basic and clinical scientists in proects on pulmonary airway and vascular biology
MD and PhD supervision

Funding

2002-2007 McPhail Charitable Trust £350,000
Bronchial epithelial cell transdifferentiation post lung transplantation

2003-2004 European Respiratory Society £35,000
Epithelial/fibroblast interactions in the genesis of OB post lung transplantation – Visiting Fellowship

2003-2005 Medical Research Council £95,443
Role of Matrix metalloproteinases in the development of OB post lung transplantation

2003-2004 Novartis Pharmaceuticals £60,000
Mechanics leading to obliterative bronchiolitis

2003-2004 Astrazeneca Foundation £20,000
Mechanics leading to obliterative bronchiolitis

2004-2005 European Respiratory Society £35,000
Role of the innate immune system in COPD exacerbations

2005-2006 Glaxo Smith Kline £75,000
The effect of corticosteroids and long acting beta agonists on primary epithelial cell pro-inflammatory activity

2005-2006 Glaxo Smith Kline £75,000
Modification of EMT in bronchial epithelial cells – effects of PDE 4 inhibitor

2005-2006 JRE Scientific Committee £38,000
Studies of Host-Epithelial cell and pathogen interactions in cystic fibrosis patients infected with Burkholderia cepacia

2005-2008 MRC £515,000
The effect of macrolide therapy on sub-clinical infection and inflammation in human lung transplantation

• Yates B, Murphy DM, Forrest IA, Ward C, Rutherford RM, Fisher AJ, Lordan JL, Dark JH, Corris PA. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. American Journal of Respiratory and Critical Care Medicine 2005, 172(6), 772-775.
• Ward C, De Soyza A, Fisher AJ, Pritchard G, Forrest I, Corris P. A descriptive study of small airway reticular basement membrane thickening in clinically stable lung transplant recipients. Journal of Heart and Lung Transplantation 2005, 24(5), 533-537.
• Corris PA, Kirby JA. A role for cytokine measurement in therapeutic monitoring of immunosuppressive drugs following lung transplantation. Clinical and Experimental Immunology 2005, 139(2), 176-178.
• Ward C, De Soyza A, Fisher AJ, Pritchard G, Forrest IA, Corris PA. Reticular basement membrane thickening in airways of lung transplant recipients is not affected by inhaled corticosteroids. Clinical and Experimental Allergy 2004, 34(12), 1905-1909.
• Rutherford RM, Fisher AJ, Hilton C, Forty J, Hasan A, Gould FK, Dark JH, Corris PA. Functional status and quality of life in patients surviving 10 years after lung transplantation. American Journal of Transplantation 2005, 5(5), 1099-1104.
• Ward C, Robertson H, Forrest IA, Lordan J, Murphy D, Dark JH, Corris PA, Jones DEJ, Kirby JA. Hypothesis: Epithelial-to-mesenchymal transition is a common cause of chronic allograft failure. In: 20th International Congress of the Transplantion Society. 2005, Vienna, Austria: Transplantation Proceedings, Elsevier.
• Curtis HJ, Bourke SJ, Dark JH, Corris PA. Lung transplantation outcome in cystic fibrosis patients with previous pneumothorax. Journal of Heart and Lung Transplantation 2005, 24(7), 865-869.
• Ward C, Forrest IA, Brownlee IA, Johnson GE, Murphy DM, Pearson JP, Dark JH, Corris PA. Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts. Thorax 2005, 60(10), 872-874.
• Ward C, Forrest IA, Murphy DM, Johnson GE, Robertson H, Cawston TE, Fisher AJ, Dark JH, Lordan JL, Kirby JA, Corris PA. Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients. Thorax 2005, 60(10), 865-871.
• Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation. Journal of Heart and Lung Transplantation 2005, 24(10), 1454-1459.
• Barr ML, Kawut SM, Whelan TP, Girgis R, Bottcher H, Sonett J, Vigneswaran W, Follette DM, Corris PA. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV: Recipient-related risk factors and markers. Journal of Heart and Lung Transplantation 2005, 24(10), 1468-1482.
• Fisher AJ, Rutherford RM, Bozzino J, Parry G, Dark JH, Corris PA. The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation. American Journal of Transplantation 2005, 5(3), 537-543.
• De Soyza A, Ellis CD, Khan CMA, Corris P, Demarco de Hormaeche R. Burkholderia Cenocepacia Lipopolysaccharide, Lipid A and Proinflammatory Activity. American Journal of Respiratory and Critical Care Medicine 2004, 170(1), 70-77.
• Klepetko W, Mayer E, Sandoval J, Trulock PE, Cachiery JL, Darteville P, Pepkezaba J, Jamieson SW, Lang I, Corris PA. Interventional and surgical modalities of treatment for pulmonary arterial hypertension. Journal of the American College of Cardiology 2004, 16(43), 73-80.
• Corris PA. Living lobar lung transplantation. Current Opinion in Organ Transplantation 2002, 7(3), 271-274.
• Fisher AJ, Donnelly SC, Pritchard G, Dark JH, Corris PA. Objective evaluation of selection criteria to assess donor lung suitability show poor discrimination of infection or inflammation. Thorax 2004, 59(5), 434-438.
• Corris PA, Milne DS, Gascoigne AD, Coaker J et al. Mononuclear phagocyte populations in the transplanted human lung. Transplantation 1998, 66, 671-673.
• Parikh S, Brownlee IA, Robertson AG, Manning NT, Johnson GE, Brodlie M, Corris PA, Ward C, Pearson JP. Are the enzymatic methods currently being used to measure bronchoalveolar lavage bile salt levels fit for purpose?. Journal of Heart and Lung Transplantation 2013, 32(4), 418-423.
• Mackay LS, Dodd S, Dougall IG, Tomlinson W, Lordan J, Fisher AJ, Corris PA. Isolation and characterisation of human pulmonary microvascular endothelial cells from patients with severe emphysema. Respiratory Research 2013, 14, 23.
• Borthwick LA, Corris PA, Mahida R, Walker A, Gardner A, Suwara M, Johnson GE, Moisey EJ, Brodlie M, Ward C, Perry JD, de Soyza A, Mann DA, Fisher AJ. TNFα From Classically Activated Macrophages Accentuates Epithelial to Mesenchymal Transition in Obliterative Bronchiolitis. American Journal of Transplantation 2013, 13(3), 621-633.
• Corris PA, Small T, Ryan VA, Lordan J, Fisher AJ, Meachery G, Johnson G, Ward C. A Randomised Controlled Trial of Azithromycin Therapy in Bronchiolitis Obliterans Syndrome (BOS) Post Lung Transplantation. In: 32nd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation. 2012, Prague, Czech Republic: Elsevier Inc.
• Robertson AGN, Krishnan A, Ward C, Pearson JP, Small T, Corris PA, Dark JH, Karat D, Shenfine J, Griffin SM. Anti-reflux surgery in lung transplant recipients: outcomes and effects on quality of life. The European Respiratory Journal 2012, 39(3), 691-697.
• Aseeri A, Brodlie M, Lordan J, Corris P, Pearson J, Ward C, Manning N. Bile Acids Are Present in the Lower Airways of People with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine 2012, 185(4), 463-463.
• Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JS, Howard LS, Pepke-Zaba J, Sheares KK, Corris PA, Fisher AJ, Lordan JL, Gaine S, Coghlan JG, Wort SJ, Gatzoulis MA, Peacock AJ. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. American Journal of Respiratory and Critical Care Medicine 2012, 186(8), 790-796.
• Suwara MI, Borthwick LA, Mahida R, Green NJ, Mayer-Barber K, Gardner A, Mann J, Wynn TA, Corris PA, Farrow SN, Mann DA, Fisher AJ. Interleukin-1 Alpha (IL-1α) Released from Injured Lung Epithelium is a Critical Alarmin Driving Activation of a Potent Inflammatory Phenotype in Lung Fibroblasts. In: Winter Meeting of the British Thoracic Society. 2012, London: BMJ Group.
• Brodlie M, Corris PA, Lordan J, Ward C. Interleukin-17 and Cystic Fibrosis Lung Disease. American Journal of Respiratory and Critical Care Medicine 2012, 185(1), 108-109.
• Majo J, Mahida R, Thampy N, Black F, Meachery G, Lordan JL, Corris PA, Fisher AJ. Prospective Evaluation of Alveolar and Bronchiolar C4d Expression in Transbronchial Biopsies from Lung Transplanted Recipients. In: 32nd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation. 2012, Prague, Czech Republic: Elsevier Inc.
• Dark JH, Karamanou D, Clark S, Mahesh P, Watson B, Corris PA, Fisher AJ. Successful Transplantation of Unusable Donor Lungs Using Ex-Vivo Lung Perfusion: The Newcastle Experience. In: 32nd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation. 2012, Prague, Czech Republic: Elsevier Inc.
• Haja Mydin H, Corris PA, Nicholson A, Perry JD, Meachery G, Marrs EC, Peart S, Fagan C, Lordan JL, Fisher AJ, Gould FK. Targeted Antibiotic Prophylaxis for Lung Transplantation in Cystic Fibrosis Patients Colonised with Pseudomonas aeruginosa Using Multiple Combination Bactericidal Testing. Journal of Transplantation 2012, 2012, 135738.
• Mahida RY, Suwara M, Johnson G, Mann D, Corris PA, Borthwick L, Fisher AJ. Alarmins in bronchiolitis obliterans syndrome after lung transplantation. In: Thorax: Winter Meeting of the British Thoracic Society. 2011, Westminster, UK: BMJ Group.
• Corris PA. Alternatives to Lung Transplantation: Treatment of Pulmonary Arterial Hypertension. Clinics in Chest Medicine 2011, 32(2), 399-410.
• Mydin HNH, Macnair A, Corris PA, Fisher AJ, Gould FK, Meachery G, Lordan JL. Cystic fibrosis, lung transplantation and clostridium difficile associated disease. In: Transplant International: 15th Congress of the ESOT and 22nd Annual Conference of the BSHI. 2011, Glasgow, UK: Wiley-Blackwell Publishing Ltd.
• Lordan JL, Corris PA. Pulmonary arterial hypertension and lung transplantation. Expert Review of Respiratory Medicine 2011, 5(3), 441-454.
• Mydin HNH, Corris PA, Meachery G, Nicholson A, Peart S, Fagan C, Lordan JL, Fisher AJ, Gould FK. Targeted Antibiotic Prophylaxis for Lung Transplantation in Cystic Fibrosis Patients Colonised with Pseudomonas Aeruginosa. In: Journal of Heart and Lung Transplantation: 31st Annual Meeting and Scientific Sessions on International Society for Heart and Lung Transplantation. 2011, San Diego, California, USA: Elsevier Inc.
• Crackett RM, Day MB, DeSoyza JR, Lordan JL, Fisher AJ, MacGowan G, Allcock R, Parry G, Corris PA. Ten Year Survival in Incident Cases of Idiopathic Pulmonary Arterial Hypertension (IPAH) in the Modern Era. In: Journal of Heart and Lung Transplantation: 31st Annual Meeting and Scientific Sessions on International Society for Heart and Lung Transplantation. 2011, San Diego, California, USA: Elsevier Inc.
• Suwara MI, Mahiba R, Borthwick LA, Mann J, Corris PA, Farrow SN, Mann DA, Fisher A. The Epithelial Alarmin, Interleukin 1 alpha (IL-1 alpha), Is a Potential Fibrogenic Factor in Bronchiolitis Obliterans Syndrome (BOS). In: Journal of Heart and Lung Transplantation: 31st Annual Meeting and Scientific Sessions on International Society for Heart and Lung Transplantation. 2011, San Diego, California, USA: Elsevier Inc.
• Hester KLM, Wiscombe S, Parry G, Meachery G, DeSoyza A, Lordan J, Fisher A, Corris PA. The impact of BMI on survival of patients with cystic fibrosis undergoing lung transplantation: a single centre experience. In: 34th European Cystic Fibrosis Society Conference. 2011, Hamburg, Germany: Elsevier B.V.
• Fisher AJ, Corris PA. The mortality of treated acute PE [reply]. Thorax 2011, 66(3), 262.
• Savelev S, Perry J, Bourke S, Taylor R, Fisher A, Corris P, Jary H, Petrie M, De Soyza A. Volatile biomarkers of Pseudomonas aeruginosa in cystic fibrosis and non cystic fibrosis bronchiectasis. Letters in Applied Microbiology 2011, 52(6), 610-613.
• Fisher A, Corris P. Authors' reply. Thorax 2010, 66, 262.
• Savelev S, Perry J, Bourke SJ, Taylor R, Fisher AJ, Petrie M, Corris PA, De Soyza A. Identification of pseudomonas aeruginosa infection via volatile organic compounds in sputum headspace gases. In: Thorax: British Thoracic Society Winter Meeting. 2010, Westminster, UK: BMJ Group.
• Mackay LS, Dodd S, Tomlinson W, Dougall I, Walden H, Isherwood B, Gardner A, Borthwick L, Brown KP, Foster M, Fisher AJ, Corris PA. Microvascular endothelial cell apoptosis and dysregulation of vascular endothelial growth factor receptor 2 (VEGF-R2) in response to cigarette smoke. New insights into the pathogenesis of emphysema. In: Thorax: British Thoracic Society Winter Meeting. 2010, Westminster, UK: BMJ Group.
• Brodlie M, McKean MC, Johnson GE, Anderson AE, Hilkens CM, Fisher AJ, Corris PA, Lordan JL, Ward C. Raised interleukin-17 is immuno-localised to neutrophils in cystic fibrosis lung disease. European Respiratory Journal 2010, 37(6), 1378-1385.
• Borthwick LA, Brodlie M, Johnson GE, Ward C, Perry J, Corris PA, De-Soyza A, Fisher AJ. The M1 macrophage phenotype accentuates TGF-beta 1 driven epithelial to mesenchymal transition (EMT) via the secretion of TNF alpha. In: Thorax: British Thoracic Society Winter Meeting. 2010, Westminster, UK: BMJ Group.
• Anderson RL, Hiemstra PS, Forrest IA, Lordan J, Corris PA, Fisher AJ. Antimicrobial peptides and airway innate immunity in the pathophysiology of bronchiolitis obliterans syndrome (BOS) after lung transplantation. In: JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2006, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA: ELSEVIER SCIENCE INC.
• Botha P, Archer L, Anderson RL, Lordan J, Dark JH, Corris PA, Gould FK, Fisher A. Colonization of lung transplant recipients with Pseudomonas Aeruginosa and the development of bronchiolitis obliterans syndrome. The Journal of Heart and Lung Transplantation 2006, 25(2), S82.
• Forrest IA, Ward C, Murphy DM, Johnson GE, Jones D, Lordan JL, Cawston TE, Corris PA. Hepatocyte growth factor - A link between neutrophilic inflammation and BOS?. The Journal of Heart and Lung Transplantation 2006, 25(2), S91.
• Anderson RL, Hiemstra PS, Forrest IA, Proud D, Ward C, Lordan J, Corris PA, Fisher AJ. The antimicrobial peptide, human beta defensin-2, in acute rejection after human lung transplantation. In: Journal of Heart and Lung Transplantation: 26th Annual Meeting and Scientific Sessions International Society for Heart and Lung Transplantation. 2006, Madrid, Spain: Elsevier Inc.
• Botha P, Archer L, Anderson RL, Lordan J, Dark JH, Corris PA, Gould FK, Fisher A. The role of primary graft dysfunction or recurrent acute rejection episodes in the development of Pseudomonas colonisation after lung transplantation. In: Journal of Heart and Lung Transplantation: 26th Annual Meeting and Scientific Sessions International Society for Heart and Lung Transplantation. 2006, Madrid, Spain: Elsevier Inc.
• Yates B, Ward C, Murphy D, Forrest I, Fisher AJ, Lordan J, Corris PA. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome (BOS) following lung transplantation. In: Journal of Heart and Lung Transplantation: 25th Anniversary Meeting of the International Society for Heart and Lung Transplantation. 2005, Philadelphia, Pennsylvania, USA: Elsevier Inc.
• Forrest IA, Murphy DM, Lordan JL, Pritchard G, Jones D, Robertson H, Cawston TE, Dark JH, Kirby JA, Ward C, Corris PA. Epithelial to mesenchymal transition in clinically stable lung transplant recipients. In: Journal of Heart and Lung Transplantation: 25th Anniversary Meeting of the International Society for Heart and Lung Transplantation. 2005, Philadelphia, Pennsylvania, USA: Elsevier Inc.
• Forrest IA, Nicholson L, Platt R, Ward C, Dark JH, Middleton PG, Corris PA. Genetic polymorphisms and bronchiolitis obliterans syndrome post lung transplantation. In: Journal of Heart and Lung Transplantation: The International Society for Heart and Lung Transplantation Twenty-Fifth Anniversary Meeting and Scientific Sessions. 2005, Philadelphia, Pennsylvania, USA: Elsevier Inc.
• Forrest IA, Krause A, Corris PA, Dark JH, Gould FK. Negative association between CMV-viraemia and bronchiolitis obliterans syndrome in lung transplant recipients. In: Journal of Heart and Lung Transplantation: 25th Anniversary Meeting of the International Society for Heart and Lung Transplantation. 2005, Philadelphia, Pennsylvania, USA: Elsevier Inc.
• Corris PA, Fisher AJ, Rutherford R, Lordan J. The feasibility of complete withdrawal of oral corticosteroids following lung transplantation. In: Journal of Heart and Lung Transplantation: 25th Anniversary Meeting of the International Society for Heart and Lung Transplantation. 2005, Philadelphia, Pennsylvania, USA: Elsevier Inc.
• Allcock RJ, Forrest I, Corris PA, Crook PR, Griffiths ID. A study of the prevalence of systemic sclerosis in northeast England. Rheumatology 2004, 43(5), 596-602.
• Ward C, Headland L, Vest S, Brownlee IA, Forrest IA, Ward TA, Pritchard G, Murphy DM, Pearson JP, Dark J, Corris P. Clinically silent gastric aspiration is common in lung allografts. In: Winter Meeting of the British Thoracic Society. 2004, London: Thorax: BMJ Publishing Group.
• Forrest IA, Murphy D, Lordan JL, Pritchard GE, Jones D, Robertson H, Cawston TE, Dark JH, Kirby JA, Corris PA, Ward C. Epithelial to mesenchymal transition in clinically stable lung transplantation. In: Winter Meeting of the British Thoracic Society. 2004, London: Thorax: BMJ Publishing Group.
• Forrest IA, Platt RE, Nicholson L, Pritchard G, Murphy D, Ward C, Corris PA, Middleton PG. Genotypic risk factors for the development of the bronchiolitis oblitererans syndrome (BOS) after lung transplantation. In: Winter Meeting of the British Thoracic Society. 2004, London: Thorax: BMJ Publishing Group.
• Murphy DM, Forrest IA, Ward C, Pritchard G, Jones D, Egan JJ, Cawston TE, Corris PA, Lordan JL. IL-17 stimulates IL-8 release in primary epithelial cell cultures derived from lung allografts. In: Winter Meeting of the British Thoracic Society. 2004, London: Thorax: BMJ Publishing Group.
• Brownlee IA, Ward C, Forrest I, Pritchard G, Murphy D, Dark J, Corris PA, Pearson JP. Pepsin detection in the lungs of transplant patients: Evidence of gastric refluxate. In: 105th Annual Meeting of the American Gastroenterological Association. 2004, New Orleans, LA, USA: W.B. Saunders Co.
• De Soyza A, Morris K, Mcdowell A, Doherty C, Archer L, Perry J, Govan JRW, Corris PA, Gould KF. Burkholderia cepacia complex genomovar distribution and clonality in cystic fibrosis patients referred to a UK transplant centre. In: Thorax: Winter Meeting of the British Thoracic Society. 2003, London, UK: BMJ Group.
• De Soyza A, Morris K, Perry J, Doherty C, Stock F, Holland SM, Gould K, Govan JR, Corris PA. Divergent pro-inflammatory activity of B cepacia complex strains dependent on patient diagnosis: Cystic fibrosis vs chronic granulomatous disease. In: Thorax: Winter Meeting of the British Thoracic Society. 2003, London, UK: BMJ Group.
• Rutherford RM, Fisher AJ, Dark JH, Forty J, Hilton C, Hasan A, Corris PA. Functional status of 10 year survivors after lung transplantation. In: Thorax: Winter Meeting of the British Thoracic Society. 2003, London, UK: BMJ Group.
• De Soyza A, Corris PA. Lung transplantation and the Burkholderia cepacia complex. Journal of Heart and Lung Transplantation 2003, 22(9), 954-958.
• de Soyza A, Dark JH, Corris PA. Outcomes of 92 adult CF patients referred to a UK transplant centre; Single centre prognostic modelling. In: Thorax: Winter Meeting of the British Thoracic Society. 2003, London, UK: BMJ Group.
• Ward C, Camara M, Forrest I, Rutherford B, Pritchard G, Daykin M, De Soyza A, Fisher AJ, Williams P, Corris PA. The presence of quorum-sensing signal molecules in clinically stable lung. In: European Respiratory Journal: 1st Lung Science Meeting of the European Respiratory Society. 2003, Taormina, Italy: European Respiratory Society.
• Forrest IA, Ward C, Pritchard G, Rowan AD, Cawston TE, Corris PA. Co-localisation of MMP-9 with neutrophils in stable lung transplant recipients - A potential role in Bronchiolitis Obliterans. In: Thorax: Winter Meeting of the British Thoracic Society. 2002, London: BMJ Group.
• De Soyza A, De Hormaeche RD, Corris P. Lipopolysaccharide structural profiles are not altered in Genomovar III Burkholderia cepacia quorum sensing knockouts. In: Thorax: Winter Meeting of the British Thoracic Society. 2002, London: BMJ Group.
• Curtis HJ, Bourke SJ, Corris PA, Dark JH. Lung transplantation outcome in cystic fibrosis patients with previous pleural procedures. In: Thorax: Winter Meeting of the British Thoracic Society. 2002, London: BMJ Group.
• De Soyza A, Gould K, Parry G, Dark JH, Corris PA. Sequential single lung transplantation for septic lung disease; A single centre comparison between CF and non-CF bronchiectasis. In: Thorax: Winter Meeting of the British Thoracic Society. 2002, London: BMJ Group.
• Ward C, De Soyza A, Fisher A, Pritchard G, Corris P. Small airway reticular basement membrane (RBM) thickening in clinically stable lung transplant recipients (SLTR) is not affected by three months treatment with inhaled corticosteroids (ICS). In: Thorax: Winter Meeting of the British Thoracic Society. 2002, London: BMJ Group.
• Ward C, Camara M, Forrest I, Rutherford B, Pritchard G, Daykin M, De Soyza A, Fisher AJ, Williams P, Corris PA. The presence of quorum sensing signal molecules in clinically stable lung allograft recipients suggests bacterial biofilm biology. In: Thorax: Winter Meeting of the British Thoracic Society. 2002, London: BMJ Group.
• Shaw RJ, Djukanovic R, Tashkin DP, Millar AB, Du Bois RM, Corris PA. The role of small airways in lung disease. Respiratory Medicine 2002, 96(2), 67-80.
• De Soyza A, De Hormaeche RD, Corris P. Variability in pro-inflammatory activity of purified lipopolysaccharide (LPS) from selected Burkholderia cepacia Genomovars; The role of LPS structural differences and chemotype. In: Thorax: Winter Meeting of the British Thoracic Society. 2002, London: BMJ Group.
• Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, Wheeler L, Phillips JA, Newman J, Williams D, Galie N, Manes A, McNeil K, Yacoub M, Mikhail G, Rogers P, Corris P, Humbert M, Donnai D, Martensson G, Tranebjaerg L, Loyd JE, Trembath RC, Nichols WC. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. American Journal of Human Genetics 2001, 68(1), 92-102.
• De Soyza A, McDowell A, Archer L, Dark JH, Elborn SJ, Mahenthiralingam E, Gould K, Corris PA. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 2001, 358(9295), 1780-1781.
• Morgan M, Carrie S, Corris P, Wilson JA. Cyst-leukotriene (cys-LT1) receptors in nasal polyps. In: IV Symposium Experimental Rhinology and Immunology of the Nose (SERIN). 2001, London, UK: Wiley-Blackwell Publishing Ltd.
• De Soyza A, Egan C, Ellis CD, Mcdowell A, Elborn S, De Hormaeche RD, Corris PA. Differential cytokine induction profiles by Burkholderia cepacia genomovars is not explained by LPS chemotypes. In: Thorax. 2001, BMJ Group.
• De Soyza A, Small T, Higgins B, Corris P. Do asthma studies really apply to primary and secondary care asthmatics?. In: Thorax. 2001, BMJ Group.
• Allcock RJ, Day MB, Crackett RM, Corris PA. Exercise capacity in pulmonary arterial hypertension due to congenital heart disease treated with Iloprost or UT 15. In: Thorax. 2001, BMJ Group.
• Small T, De Soyza A, Corris PA. Exhaled nitric oxide (ENO) in pulmonary transplant recipients and the influence of Mycophenolate (MMF). In: Thorax. 2001, BMJ Group.
• Ward TA, Pritchard G, Corris PA. Success of sputum induction as a method of monitoring inflammatory events following lung transplantation. In: Thorax. 2001, BMJ Group.
• De Soyza A, Pirrie S, Corris PA. The 6 minute walk test's correlation with FEV1 in 50 Cystic Fibrosis patients referred for lung transplantation. In: Thorax. 2001, BMJ Group.
• Cunningham B, Corris P. The interface between primary and secondary care. Clinical Medicine 2001, 1(6), 516-516.
• Egan C, Pritchard G, De Soyza A, Corris PA. A comparison of induced sputum and BAL cell profiles in pulmonary transplant recipients. In: THORAX. 2000.
• Fisher AJ, Wardle J, Dark JH, Corris PA. Acute lung injury after lung transplantation: Risk factors and long term survival implications. Thorax 2000, 55(3), A2-.
• Egan C, Pritchard G, De Soyza A, Corris PA. Efficacy and safety of inducing sputum in lung transplant patients with two nebuliser devices. In: THORAX. 2000.
• Milne DS, Moy JV, Corris PA, Robertson H, De Soyza A, Kirby JA, Cunningham AC. Intragraft Proliferating T Lymphocytes are associated with Moderate Acute Pulmonary Rejection 1. Transplantation 2000, 69(9), 1981-1984.
• Christie G, Rao J, Hilton CJ, Forty J, Hassan A, Pillay T, Dark JH, Corris PA. Lung transplantation for non cystic fibrosis bronchiectasis. In: THORAX. 2000.
• Day MB, Brodie J, Corris PA. Patient acceptability of hydrofluoalkane (CFC-free) inhalers. In: THORAX. 2000.
• De Soyza A, Corris PA, Archer L, McDowell A, Moore J, Elborn S, Dark JH, Gould K. Pulmonary transplantation for CF; The effect of B. cepacia genomovars on outcomes. In: THORAX. 2000.
• Melville AMS, Wardle J, Hasan A, Pillay T, Hilton CJ, Forty J, Dark JH, Corris PA. Single lung transplantation for emphysema: 1987-2000 and beyond. In: THORAX. 2000.
• Allcock RJ, Small T, Corris PA. The effect of oral sildenafil on exhaled nitric oxide in normal subjects. In: THORAX. 2000.
• De Soyza A, Egan C, Ellis CD, McDowell A, Moore J, Elborn S, De Hormaeche R, Corris PA. The role of genomovars in Burkholderia cepacia proinflammatory activity. In: THORAX. 2000.
• McMahon S, Small T, Higgins BG, Corris PA. The use of a novel patient activity monitor to assess the therapeutic effect of adding salmeterol to regular therapy in patients with chronic obstructive pulmonary disease(COPD). In: THORAX. 2000.
• Corris PA. Acute pulmonary embolism: clinical aspects. HOSPITAL MEDICINE 1998, 59(5), 369-371.
• Corris PA. Untitled - Commentary. THORAX 1998, 53(7), 619-619.
• Corris PA. Pregnancy following a single lung transplant - Commentary. THORAX 1996, 51(11), 1164-1165.
• CORRIS PA. POST HEART/LUNG TRANSPLANTATION MANAGEMENT. In: JOURNAL OF THE ROYAL SOCIETY OF MEDICINE. 1995.
• CORRIS P. PULMONARY-INFILTRATES FOLLOWING BONE-MARROW TRANSPLANTATION. THORAX 1994, 49(10), 1042-1042.
• CORRIS PA, DARK JH. ETIOLOGY OF ASTHMA - LESSONS FROM LUNG TRANSPLANTATION. LANCET 1993, 341(8857), 1369-1371.
• CORRIS PA, DARK JH. THE CURRENT STATE OF LUNG TRANSPLANTATION - REPLY. THORAX 1990, 45(5), 424-424.
• KIRK AJB, GOULD FK, FREEMAN R, CORRIS PA, DARK JH. FLUCONAZOLE AND CANDIDOSIS. LANCET 1989, 1(8633), 339-339.
• DARK J, CORRIS PA. THE CURRENT STATE OF LUNG TRANSPLANTATION. THORAX 1989, 44(9), 689-692.
• FREEMAN R, CORRIS PA, GOULD K, MCGREGOR CGA. PULMONARY COMPLICATIONS AFTER CARDIAC TRANSPLANTATION. In: THORAX. 1988.
• KELLY CA, CORRIS PA, ADAMS PC, MURRAY A, GIBSON GJ. EFFECTS OF THEOPHYLLINE ON CARDIAC-RHYTHM IN PATIENTS WITH HYPOXEMIC CHRONIC AIRWAYS OBSTRUCTION. In: THORAX. 1986.
• CORRIS P, GIBSON J. NIFEDIPINE ENHANCES THE BRONCHODILATOR EFFECT OF SALBUTAMOL - REPLY. THORAX 1985, 40(5), 399-399.
• GILMARTIN JJ, CORRIS PA, STONE TN, GIBSON GJ. EFFECTS OF DIAZEPAM AND CHLORMETHIAZOLE ON VENTILATORY CONTROL IN NORMAL SUBJECTS. In: CLINICAL SCIENCE. 1984.
• CORRIS PA, ELLIS DA, NARIMAN S, GIBSON GJ. USE OF PREOPERATIVE PERFUSION SCANNING TO PREDICT EXERCISE PERFORMANCE AFTER PNEUMONECTOMY FOR CARCINOMA OF THE BRONCHUS. In: CLINICAL SCIENCE. 1983.
• NEVILLE E, CORRIS PA, VIVIAN J, NARIMAN S, GIBSON GJ. LESSON OF THE WEEK - NEBULIZED SALBUTAMOL AND ANGINA. BRITISH MEDICAL JOURNAL 1982, 285(6344), 796-797.